Many cases have been heard before the Court of Appeals for the Federal Circuit dealing with substantive patent issues, like questions involving anticipation under 35 U.S.C. §102, obviousness under 35...
The United States Attorney’s office in San Jose, California, recently indicted Uber Technologies, Inc.’s former autonomous driving car guru, Anthony Levandowski, with thirty-three counts of trade...
Today is Constitution Day. On this day, September 17, 1787, the U.S. Constitution was signed thirty-nine Founding Fathers, ushering the birth of the United States. Several clauses in the...
The Oracle OpenWorld 2019 conference will be held in San Francisco from September 16-19, 2019. To commemorate Oracle OpenWorld, the blog will highlight a recently-issued Oracle, Inc. patent. U.S....
On August 23, 2019, Gilead Sciences, Inc. petitioned the PTAB for inter partes review of three patents behind its blockbuster TRUVADA® HIV-prevention drug. The patents, U.S. Patent No....
U.S. Patent No. 10,245,237 B2 (‘237) issued on April 2, 2019, for “Compressed Tablet Containing Cannabidiol, Method for its Manufacture and Use of Such Tablet in Oral Treatment of Psychosis or...
On August 26, 2019, the U.S. Drug Enforcement Administration (DEA) announced an expansion of a federal program allowing legalized cannabis research, by allowing additional applications from cannabis...
Source: U.S. Patent No. 10,337,029 B2, July 2, 2019, to Jennifer A. Doudna, Martin Jinek, Krzysztof Chylinski, Emmanuelle Charpentier (inventors); Regents of the University of California, University...
Source: U.S. Patent D489,299 S, May 4, 2004, Craig Metros, Patrick J. Schiavone, & Tyler J. Blake (inventors); Ford Global Technologies, LLC (assignee) On July 23, 2019, the Court of Appeals for the...
On June 25, 2019, the Court of Appeals for the Federal Circuit handed down CellSpin Soft, Inc. v. Fitbit, Inc., in what is an important case dealing with patent-eligibility under 35 U.S.C. §101,...